Skip to main content

Inpharmatica to Model Structures of GPCRs for Procter and Gamble Pharmaceuticals

NEW YORK, May 18 (GenomeWeb News) - Inpharmatica will develop computational structural models of families of human G-protein coupled receptors for Procter and Gamble Pharmaceuticals, the company said today.

 

Under the agreement, P&GP, a subsidiary of Procter and Gamble, will fund a research program at London-based Inpharmatica and will pay license fees for discoveries resulting from the project.

 

Inpharmatica will use its PharmaCarta platform to create computational structural models and to identify chemotypes for families of human G-protein coupled receptors.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.